107. Future Oncol. 2018 Jul 20. doi: 10.2217/fon-2017-0713. [Epub ahead of print]Healthcare delay in breast cancer patients: a case study in a low-densitypopulation region from Mexico.Rangel-Méndez JA(1), Novelo-Tec JF(2), Sánchez-Cruz JF(3), Cedillo-Rivera R(4),Moo-Puc RE(1).Author information: (1)Unidad de Investigación Médica Yucatán, Unidad Médica de Alta Especialidad,Hospital de Especialidades del Centro Médico Nacional "Ignacio García Téllez",Instituto Mexicano del Seguro Social, Calle 41 No. 439, Col. Industrial, Mérida, Yucatán 97150, México.(2)Unidad de Medicina Familiar número 58, Delegación Estatal Yucatán, InstitutoMexicano del Seguro Social, Calle 42 999 X 127 A Y 131, Serapio Rendón II,Mérida, Yucatán 97285, México.(3)Coordinación de Investigación, Delegación Estatal Yucatán, Instituto Mexicano del Seguro Social, Calle 41 No. 439, Col. Industrial, Mérida, Yucatán 97150,México.(4)Unidad Interinstitucional de Investigación Clínica y Epidemiológica, Facultad de Medicina, Universidad Autónoma de Yucatán, Avenida Itzáes No. 498 x 86 Y 59A, Centro, Mérida, Yucatán 97000, México.AIM: To describe delay intervals, their impact on clinical stage and initiationof first oncologic treatment, and evaluate associated factors in breast cancerpatients in Yucatan, Mexico, a low-density population region.PATIENTS & METHODS: A retrospective analysis was done of 92 medical records, and bivariate and multivariate models applied to identify associations betweenhealthcare delay and several factors.RESULTS: System delay accounted for most of the delay (median: 86 days; 61% ofdelay). Socioeconomic status and delivery to tertiary-care hospital predicteddelay. Clinical stage determined initiation of first oncologic treatment.CONCLUSION: Delay in treatment was largely due to system delay. Only a fewvariables explained this delay. Clinical stage had the strongest effect oninitiation of first oncologic treatment.DOI: 10.2217/fon-2017-0713 PMID: 30027752 